Selenium-containing agents are more and more considered as an innovative potential treatment option for cancer. Light is shed not only on the considerable advancements made in understanding the complex biology and chemistry related to selenium-containing small molecules but also on Se-nanoparticles. Numerous Se-containing agents have been widely investigated in recent years in cancer therapy in relation to tumour development and dissemination, drug delivery, multidrug resistance (MDR) and immune system-related (anti)cancer effects. Despite numerous efforts, Se-agents apart from selenocysteine and selenomethionine have not yet reached clinical trials for cancer therapy. The purpose of this review is to provide a concise critical overview of the current state of the art in the development of highly potent target-specific Se-containing agents.

Selenium-Containing Agents Acting on Cancer—A New Hope? / Garbo, Sabrina; Di Giacomo, Silvia; Łażewska, Dorota; Honkisz-Orzechowska, Ewelina; Di Sotto, Antonella; Fioravanti, Rossella; Zwergel, Clemens; Battistelli, Cecilia. - In: PHARMACEUTICS. - ISSN 1999-4923. - 15:1(2023). [10.3390/PHARMACEUTICS15010104]

Selenium-Containing Agents Acting on Cancer—A New Hope?

Garbo, Sabrina;Di Giacomo, Silvia;Di Sotto, Antonella;Fioravanti, Rossella;Zwergel, Clemens
;
Battistelli, Cecilia
2023

Abstract

Selenium-containing agents are more and more considered as an innovative potential treatment option for cancer. Light is shed not only on the considerable advancements made in understanding the complex biology and chemistry related to selenium-containing small molecules but also on Se-nanoparticles. Numerous Se-containing agents have been widely investigated in recent years in cancer therapy in relation to tumour development and dissemination, drug delivery, multidrug resistance (MDR) and immune system-related (anti)cancer effects. Despite numerous efforts, Se-agents apart from selenocysteine and selenomethionine have not yet reached clinical trials for cancer therapy. The purpose of this review is to provide a concise critical overview of the current state of the art in the development of highly potent target-specific Se-containing agents.
2023
selenium; cancer; cancer therapy; immunotherapy; small organic Se-containing compounds; Se-nanoparticles
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
Selenium-Containing Agents Acting on Cancer—A New Hope? / Garbo, Sabrina; Di Giacomo, Silvia; Łażewska, Dorota; Honkisz-Orzechowska, Ewelina; Di Sotto, Antonella; Fioravanti, Rossella; Zwergel, Clemens; Battistelli, Cecilia. - In: PHARMACEUTICS. - ISSN 1999-4923. - 15:1(2023). [10.3390/PHARMACEUTICS15010104]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1663202
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 15
  • ???jsp.display-item.citation.isi??? 7
social impact